Jacobs Levy Equity Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-151
| Closed | -$144K | – | 1078 |
|
2016
Q3 | $144K | Hold |
151
| – | – | ﹤0.01% | 940 |
|
2016
Q2 | $215K | Hold |
151
| – | – | ﹤0.01% | 993 |
|
2016
Q1 | $185K | Sell |
151
-33
| -18% | -$40.4K | ﹤0.01% | 980 |
|
2015
Q4 | $238K | Sell |
184
-4
| -2% | -$5.17K | ﹤0.01% | 682 |
|
2015
Q3 | $272K | Buy |
188
+39
| +26% | +$56.4K | 0.01% | 672 |
|
2015
Q2 | $329K | Buy |
149
+8
| +6% | +$17.7K | 0.01% | 633 |
|
2015
Q1 | $419K | Buy |
141
+36
| +34% | +$107K | 0.01% | 599 |
|
2014
Q4 | $346K | Buy |
105
+84
| +400% | +$277K | 0.01% | 659 |
|
2014
Q3 | $73K | Sell |
21
-59
| -74% | -$205K | ﹤0.01% | 793 |
|
2014
Q2 | $308K | Buy |
80
+20
| +33% | +$77K | 0.01% | 708 |
|
2014
Q1 | $244K | Buy |
+60
| New | +$244K | ﹤0.01% | 785 |
|